Glucose Health Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Murray Fleming

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure10.2yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Murray Fleming's remuneration changed compared to Glucose Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

-US$357k

Jun 30 2022n/an/a

-US$497k

Mar 31 2022n/an/a

-US$543k

Dec 31 2021US$24kUS$24k

-US$339k

Compensation vs Market: Insufficient data to establish whether Murray's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare Murray's compensation with company performance.


CEO

Murray Fleming (61 yo)

10.2yrs

Tenure

US$84,000

Compensation

Mr. Murray S. Fleming has been the Chief Executive Officer of Glucose Health, Inc. since October 01, 2014 and its Chief Financial Officer since February 10, 2015. Mr. Fleming serves as Controller of Nacel...


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:14
End of Day Share Price 2024/12/23 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Glucose Health, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution